Literature DB >> 14987254

Human skin: source of and target organ for angiotensin II.

U Muscha Steckelings1, Tanja Wollschläger, Jörg Peters, Beate M Henz, Barbara Hermes, Metin Artuc.   

Abstract

The present study examined the expression of angiotensin receptors in human skin, the potential synthesis of angiotensin II (Ang II) in this location and looked for a first insight into physiological functions. AT1 and AT2 receptors were found within the epidermis and in dermal vessel walls. The same expression pattern was found for angiotensinogen, renin and angiotensin-converting enzyme (ACE). All components could additionally be demonstrated at mRNA level in cultured primary keratinocytes, melanocytes, dermal fibroblasts and dermal microvascular endothelial cells, except for AT2 receptors in melanocytes. The ability of cutaneous cells to synthesize Ang II was proved by identifying the molecule in cultured keratinocytes. Furthermore, in artificially wounded keratinocyte monolayers, ACE-mRNA expression was rapidly increased, and enhanced ACE expression was still found in cutaneous human scars 3 months after wounding. These findings suggest that the complete renin-angiotensin system is present in human skin and plays a role in normal cutaneous homeostasis as well as in human cutaneous wound healing.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14987254     DOI: 10.1111/j.0906-6705.2004.0139.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  34 in total

1.  Detection of Angiotensin II and AT1 Receptor Concentrations in Keloid and Hypertrophic Scar.

Authors:  Feizollah Niazi; Seyed Hassan Hooshyar; Keshvad Hedayatyanfard; Seyed Ali Ziai; Farideh Doroodgar; Sana Niazi; Behnam Habibi; Ali Asadirad
Journal:  J Clin Aesthet Dermatol       Date:  2018-10-01

Review 2.  Sympathetic control of reflex cutaneous vasoconstriction in human aging.

Authors:  Jody L Greaney; Lacy M Alexander; W Larry Kenney
Journal:  J Appl Physiol (1985)       Date:  2015-08-13

3.  Beta-arrestin2 functions as a phosphorylation-regulated suppressor of UV-induced NF-kappaB activation.

Authors:  Bing Luan; Zhenning Zhang; Yalan Wu; Jiuhong Kang; Gang Pei
Journal:  EMBO J       Date:  2005-11-24       Impact factor: 11.598

4.  Can intradermal administration of angiotensin II influence human heat loss responses during whole body heat stress?

Authors:  Naoto Fujii; Robert D Meade; Gabrielle Paull; Ryan McGinn; Imane Foudil-bey; Pegah Akbari; Glen P Kenny
Journal:  J Appl Physiol (1985)       Date:  2015-03-12

Review 5.  Deciphering the Identity of Renin Cells in Health and Disease.

Authors:  Omar Guessoum; Alexandre de Goes Martini; Maria Luisa S Sequeira-Lopez; R Ariel Gomez
Journal:  Trends Mol Med       Date:  2020-11-05       Impact factor: 11.951

6.  Activation of skin renin-angiotensin system in diabetic rats.

Authors:  Shao Yun Hao; Meng Ren; Chuan Yang; Diao Zhu Lin; Li Hong Chen; Ping Zhu; Hua Cheng; Li Yan
Journal:  Endocrine       Date:  2011-04-12       Impact factor: 3.633

7.  Targeting the renin-angiotensin-aldosterone system in fibrosis.

Authors:  Mohammad AlQudah; Taben M Hale; Michael P Czubryt
Journal:  Matrix Biol       Date:  2020-05-16       Impact factor: 11.583

8.  Effects of combined radiation and burn injury on the renin-angiotensin system.

Authors:  Sachin S Jadhav; Natasha Sharma; Christopher J Meeks; Nicholas M Mordwinkin; Theresa B Espinoza; Norma R Roda; Gere S DiZerega; Colin K Hill; Stan G Louie; Kathleen E Rodgers
Journal:  Wound Repair Regen       Date:  2012-12-11       Impact factor: 3.617

9.  Angiotensin II stimulates melanogenesis via the protein kinase C pathway.

Authors:  Li-Hong Liu; Xin Fan; Zhi-Kuan Xia; Xu-Xi An; Rong-Ya Yang
Journal:  Exp Ther Med       Date:  2015-08-14       Impact factor: 2.447

10.  Angiotensin II type 1 receptor blockade corrects cutaneous nitric oxide deficit in postural tachycardia syndrome.

Authors:  Julian M Stewart; Indu Taneja; June Glover; Marvin S Medow
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-11-09       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.